Cargando…
Gene therapy using genome‐edited iPS cells for targeting malignant glioma
Glioblastoma is characterized by diffuse infiltration into the normal brain. Invasive glioma stem cells (GSCs) are an underlying cause of treatment failure. Despite the use of multimodal therapies, the prognosis remains dismal. New therapeutic approach targeting invasive GSCs is required. Here, we s...
Autores principales: | Tamura, Ryota, Miyoshi, Hiroyuki, Imaizumi, Kent, Yo, Masahiro, Kase, Yoshitaka, Sato, Tsukika, Sato, Mizuto, Morimoto, Yukina, Sampetrean, Oltea, Kohyama, Jun, Shinozaki, Munehisa, Miyawaki, Atsushi, Yoshida, Kazunari, Saya, Hideyuki, Okano, Hideyuki, Toda, Masahiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10487333/ https://www.ncbi.nlm.nih.gov/pubmed/37693056 http://dx.doi.org/10.1002/btm2.10406 |
Ejemplares similares
-
ET-1 STEM CELL-BASED GENE THERAPY FOR MALIGNANT GLIOMA USING GENOME-EDITED HUMAN INDUCED PLURIPOTENT STEM CELLS
por: Tamura, Ryota, et al.
Publicado: (2022) -
Visualization of spatiotemporal dynamics of human glioma stem cell invasion
por: Tamura, Ryota, et al.
Publicado: (2019) -
Neuroprotective Effects of Genome-Edited Human iPS Cell-Derived Neural Stem/Progenitor Cells on Traumatic Brain Injury
por: Imai, Ryotaro, et al.
Publicado: (2023) -
A Pilot Study of the Adverse Events Caused by the Combined Use of Bevacizumab and Vascular Endothelial Growth Factor Receptor-Targeted Vaccination for Patients with a Malignant Glioma
por: Tamura, Ryota, et al.
Publicado: (2020) -
The GADD45G/p38 MAPK/CDC25B signaling pathway enhances neurite outgrowth by promoting microtubule polymerization
por: Kase, Yoshitaka, et al.
Publicado: (2022)